Indapamide Sr Pliva (Indapamide)

Indapamide acts on the distal convoluted tubule of the kidney, where it blocks the Na⁺/Cl⁻ cotransporter. This inhibition reduces sodium and chloride reabsorption, leading to increased urine output (diuresis). The resulting loss of extracellular fluid lowers blood volume, which in turn decreases arterial pressure and alleviates edema.

The specific dose of Indapamide Sr Pliva is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors such as kidney function. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for indapamide in pregnancy and lactation are limited, and the medication should only be used if the potential benefits outweigh the risks. Healthcare providers will evaluate the mother’s condition and consider alternative treatments when possible. Breastfeeding mothers should discuss potential exposure with their doctor.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class and offers a longer duration of action with a lower incidence of metabolic side effects compared with traditional thiazides such as hydrochlorothiazide. It is often chosen for patients who need effective blood‑pressure control and edema reduction while minimizing electrolyte disturbances.

Store the product at room temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children. Do not refrigerate or freeze the medication.

Indapamide Sr Pliva is taken orally, usually with a glass of water. It may be taken with or without food, as directed by the prescriber. Patients should swallow the tablet whole and avoid crushing or chewing it unless instructed otherwise.

The most serious risks include severe dehydration, significant electrolyte imbalances such as low potassium or sodium, acute kidney injury, and rare allergic reactions like rash or angioedema. Prompt medical attention is required if symptoms such as faintness, muscle weakness, rapid weight loss, or swelling occur.

Indapamide is contraindicated in individuals with known hypersensitivity to indapamide or other sulfonamide‑derived drugs. Patients with severe renal impairment, uncontrolled electrolyte disturbances, or those taking interacting medications such as lithium without close monitoring should avoid its use unless supervised by a healthcare professional.